Macquarie Group’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Macquarie Group’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-517	Closed	-$13K	–	2550
2017 Q4	$13K	Buy	+517	New	+$9.94K	﹤0.01%	2239

Macquarie Group's ENTL Position: Q1 2018 in Review

Macquarie Group sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 517 shares — an estimated $13K sold.

Macquarie Group first reported a position in ENTL in Q4 2017 and held it in 1 quarter. The position peaked at $13K in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

Macquarie Group reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Macquarie Group sold 517 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $13K.
Macquarie Group first reported a position in Entellus Medical, Inc. Common Stock in Q4 2017 and held it in 1 quarter.
Macquarie Group's Entellus Medical, Inc. Common Stock position peaked at $13K in Q4 2017.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Macquarie Group's 13F filing for Q1 2018, filed 11 May 2018.